]/dtmin, whereas lidocaine increased it, and bimakalim and BDM had no effect on d [Ca 2ϩ ]/dtmin. Each drug except bimakalim increased VR max and VRmin before ischemia; after ischemia, only BDM and nifedipine increased VR max and VRmin. Before and after ischemia, BDM and nifedipine increased AR, whereas lidocaine and bimakalim had no effect. At 30 min of reperfusion, control hearts exhibited marked Ca 2ϩ overload and depressed LVP. In each drugpretreated group Ca 2ϩ overload was reduced on reperfusion, but only the group pretreated with nifedipine exhibited both higher LVP and lower [Ca 2ϩ ]. These results show that negative inotropic drugs are less capable of reducing [Ca 2ϩ ] after ischemia so that there is a relatively larger Ca 2ϩ expenditure for contraction/relaxation after ischemia than before ischemia. Moreover, the differential effects of pretreatment with negative inotropic drugs on [Ca 2ϩ ]-LVP relationships after ischemia suggest that these drugs, especially nifedipine, can elicit cardiac preconditioning. ] in isolated hearts to better understand how positive inotropic drugs alter the dynamics of Ca 2ϩ flux and its relationship to mechanical function (11, 36) . This is especially important in hearts compromised by ischemia and reperfusion (I/R) injury (26, 28, 56, 60) and congestive heart failure (23, 31), where abnormal cytosolic Ca 2ϩ homeostasis is associated with depressed myocardial contractility and relaxation. Cardiac I/R causes long-lasting bursts of Na ϩ channel opening and prolongs Na ϩ channel inactivation that leads to Na ϩ loading and Ca 2ϩ overload by slowed or reverse Na ϩ /Ca 2ϩ exchange. The aims of this study were, first, to observe how negative inotropic drugs that work on different cardiac receptors or ion channels alter several indexes of the Ca 2ϩ -LVP relationship; second, to assess whether these drugs are equally effective after ischemia as before ischemia; and, finally, to determine whether these drugs protect the heart against I/R injury. We used the fluorescent probe indo 1-AM to simultaneously measure transient cytosolic [Ca 2ϩ ] and isovolumetric LVP during the cardiac cycle and analyzed several indexes of this relationship to better understand how different negative inotropic drugs alter Ca 2ϩ -LVP relationships before and after ischemia. Four drugs were selected. Bimakalim (Bim), an opener of ATP-sensitive K ϩ (K ATP ) channels (4, 20), shortens the cardiac AP, which in turn retards Ca 2ϩ influx per contraction. Lower concentrations of K ATP channel openers are known to elicit cardioprotection without altering AP duration (4), although the mechanism for this is unclear (19). In the normoxic
stores and SR Ca 2ϩ reuptake and efflux by ATP-dependent pumps and cation exchangers. During the plateau phase of the action potential (AP), Ca 2ϩ enters cells via Ca 2ϩ channels to trigger SR release of a relatively large amount of Ca 2ϩ so that free cytosolic [Ca 2ϩ ] increases ϳ10-fold and myofilament contraction occurs (57) . Changes in transient cytosolic Ca 2ϩ associated with contractile function have been measured in normal and diseased isolated myocytes (33, 46) . Others have measured systolic-diastolic [Ca 2ϩ ] (phasic [Ca 2ϩ ]) and contractile force in intact hearts using Ca 2ϩ -sensitive fluorescence probes (6, 15, 29) . We have compared simultaneous changes in phasic [Ca 2ϩ ] and left ventricular (LV) pressure (LVP) (3, 18, 49, 56) and their peak positive and negative derivatives (11) in hearts under normoxic and ischemic conditions. Ischemia and cardiotonic drugs alter the relationships between cytosolic Ca 2ϩ and contractility and relaxation. We have analyzed the cyclic relationship between LVP and cytosolic [Ca 2ϩ ] in isolated hearts to better understand how positive inotropic drugs alter the dynamics of Ca 2ϩ flux and its relationship to mechanical function (11, 36) . This is especially important in hearts compromised by ischemia and reperfusion (I/R) injury (26, 28, 56, 60) and congestive heart failure (23, 31) , where abnormal cytosolic Ca 2ϩ homeostasis is associated with depressed myocardial contractility and relaxation. Cardiac I/R causes long-lasting bursts of Na ϩ channel opening and prolongs Na ϩ channel inactivation that leads to Na ϩ loading and Ca 2ϩ overload by slowed or reverse Na ϩ /Ca 2ϩ exchange. The aims of this study were, first, to observe how negative inotropic drugs that work on different cardiac receptors or ion channels alter several indexes of the Ca 2ϩ -LVP relationship; second, to assess whether these drugs are equally effective after ischemia as before ischemia; and, finally, to determine whether these drugs protect the heart against I/R injury. We used the fluorescent probe indo 1-AM to simultaneously measure transient cytosolic [Ca 2ϩ ] and isovolumetric LVP during the cardiac cycle and analyzed several indexes of this relationship to better understand how different negative inotropic drugs alter Ca 2ϩ -LVP relationships before and after ischemia. Four drugs were selected. Bimakalim (Bim), an opener of ATP-sensitive K ϩ (K ATP ) channels (4, 20) , shortens the cardiac AP, which in turn retards Ca 2ϩ influx per contraction. Lower concentrations of K ATP channel openers are known to elicit cardioprotection without altering AP duration (4) , although the mechanism for this is unclear (19) . In the normoxic heart, the K ATP channel is thought to be inactive; during I/R, however, the decline in ATP results in K ATP channel activation, which in turn reduces postischemic Ca 2ϩ loading (42) . K ATP channel opening may modulate cytosolic Ca 2ϩ -controlling mechanisms, possibly through altered mitochondrial bioenergetics (13, 19, 43) . The K ATP channel located within the sarcolemmal membrane is also thought to be located in the mitochondrial membrane, but its existence in mitochondria has not been verified. These channels appear to be key elements in effecting cardiac preconditioning (20) .
2,3-Butanedione monoxime (BDM) has broad effects. It reversibly uncouples excitation from contraction to produce a negative inotropic effect in all contractile elements including those in skeletal and cardiac muscle cells. BDM retards crossbridge function by inhibiting actinomyosin ATPase, by decreasing myofilament Ca 2ϩ sensitivity (17, 21, 22, 45) , by depressing transsarcolemmal Ca 2ϩ fluxes, by reducing SR Ca 2ϩ uptake and release, and by shorting the AP (21) . Nifedipine (Nif), a dihydropyridine, blocks voltage-gated L-type Ca 2ϩ channels and is used clinically to treat angina, hypertension, and ventricular tachycardia (47, 61) . Lidocaine (Lid) depresses phase 0 of the cardiac AP by blocking the fast Na ϩ channel (10) and is used primarily as an antidysrhythmic and nerve blocking agent. Lid also depresses contractility by decreasing cytosolic [Ca 2ϩ ] secondary to enhanced forwardmode Na ϩ /Ca 2ϩ exchange with a reduction in Na ϩ influx (41) .
METHODS
Isolated heart preparation and measurements. The investigation conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996). Prior approval was obtained from the Medical College of Wisconsin Animal Studies Committee. Our preparation and measurements have been described in detail (3, 11, 36, 49, 56) . In brief, hearts were isolated from anesthetized guinea pigs (250 -300 g) and perfused by the Langendorff method at a constant pressure of 55 mmHg and at 37°C with a modified Krebs-Ringer (KR) solution equilibrated with ϳ95% O 2 and ϳ5% CO2 and containing (in mM) 137 Na ϩ , 4. LVP was measured with a transducer connected to a thin, salinefilled latex balloon inserted into the LV through a cut in the left atrium. Baseline systolic LVP was ϳ50 -55 mmHg; this was due to half normal CaCl 2 in the perfusate, the cardiodepressant effect of probenecid, and the cytosolic buffering of [Ca 2ϩ ] by the fluorescence dye indo 1. The first derivative of LVP, dLVP/dt, was derived on-line, and maximum (dLVP/dt max) and minimum (dLVP/dtmin) values represent the maximum and minimum time derivatives of LVP. Balloon volume was adjusted to maintain a diastolic LVP of 0 mmHg during the initial control period so that any increase in diastolic LVP indicated an increase in LV wall stiffness or diastolic contracture. Two pairs of bipolar electrodes were placed in each heart to monitor intracardiac electrograms, from which spontaneous atrial heart rate was determined from the right atrial beat-to-beat interval.
Coronary flow (CF) was measured at constant temperature (37°C) with a self-calibrating in-line, ultrasonic flowmeter. Coronary effluent Na ϩ , K ϩ , Ca 2ϩ , PO2, PCO2, and pH were measured off-line with an intermittently self-calibrating analyzer system (Radiometer Copenhagen ABL 505; Copenhagen, Denmark). Coronary sinus effluent was collected through a cannula inserted into the right ventricle through the pulmonary artery after the venae cavae were ligated. Coronary outflow (coronary sinus) O 2 was also measured continuously on-line with a Clark-type O2 electrode placed in the outflow. Because myocardial metabolism is altered by negative inotropic drugs and by I/R (3, 24, 59), we measured myocardial O2 consumption (MV O2) and %O 2 extraction (%O2E). MV O2 was calculated as (CF/heart weight) ϫ (arterial PO 2 Ϫ venous PO2) ϫ 24 l O2/ml, and %O2E was calculated as 100 ϫ [(arterial PO 2 Ϫ venous PO2)/arterial PO2] at 760 mmHg and 37°C.
Measurement of cytosolic and noncytosolic free Ca 2ϩ in isolated hearts. We have described details of our method to monitor, calibrate, and assess indo 1 fluorescence signals as a measure of cytosolic [Ca 2ϩ ] in the LV of isolated hearts (3, 11, 36, 49, 56) . All experiments were conducted in a light-blocking Faraday cage. Briefly, the heart was suspended via the aortic cannula in the perfusate bath at 37°C, and the distal end of a trifurcated fiberoptic cable (surface area 3.85 mm 2 ) was placed gently against the LV epicardial surface through a hole in the bath to excite the tissue with light filtered at 350 nm and recorded at 385 and 456 nm. A rubber O-ring was placed over the fiberoptic tip to seal the hole, and netting was applied around the heart for optimal contact with the fiberoptic tip. Background autofluorescence was determined for each heart after initial perfusion and equilibration for 30 min.
Each heart was then loaded with indo 1-AM for 20 -30 min with the recirculated KR solution at a final indo 1-AM concentration of 6 M. Residual interstitial indo 1-AM was washed out by perfusing the heart with standard KR solution for 20 min. Additional experiments (3 hearts for each of the 5 groups) were conducted to assess changes in tissue autofluorescence due to changes in the redox state (primarily a measure of NADH) and drug autofluorescence. None of the drugs exhibited a significant change in autofluorescence. I/R, as noted previously (37) , caused an initial increase and then a decrease in NADH; these autofluorescence values were subtracted from the fluorescence signal obtained with indo 1.
The fluorescence emissions at 385 and 456 nm (F385 and F456) were recorded using a modified luminescence spectrophotometer (SLM Aminco-Bowman II, Spectronic Instruments; Urbana, IL). The arc lamp shutter was opened only for 2.5-s recording intervals to prevent photobleaching. The F385-to-F456 ratio remained stable during the 3-h course of these studies, indicating no change in effective measured [Ca 2ϩ ]. After indo 1 was loaded, systolic-diastolic LVP was slightly altered in nonischemic hearts over this time period. Cytosolic [Ca 2ϩ ] was distinguished from total cell [Ca 2ϩ ] after the mitochondrialderived fluorescence was quenched at the end of each experiment with MnCl2 (3, 11, 36, 49, 56) . Pilot experiments using fresh sections of non-dye-loaded LV free wall (2-3 mm thick) placed between the probe tip and the LV wall from an intact dye-loaded heart showed an attenuation of 80 -85% in emission signal strength from the epicardial to endocardial surface. Although tissue underlying the fiberoptic probe in the middle myocardial band becomes infarcted in this model, the nonviable cells do not contribute to the signal because they do not have intact cell membranes.
Simultaneous [Ca 2ϩ ] and LVP recordings were obtained at designated time points. Customized software was developed in MATLAB (Mathworks, Natick, MA) for off-line signal processing of recorded data. LVP and fluorescence data were digitally lowpass filtered using a fourth-order bidirectional Butterworth filter at 25 Hz. Data were analyzed for peak systolic, peak diastolic, and systolic-diastolic LVP (mmHg) and [ The index of area [Ca 2ϩ ]/area LVP, or AR, was used to assess the net amount of free Ca 2ϩ moved in and out of the cytosol to effect cardiac (potential) work assessed over one beat. Area [Ca 2ϩ ] was defined as the integral of the mean systolic minus diastolic free [Ca 2ϩ ] during a mean cardiac cycle, i.e., the total amount of [Ca 2ϩ ] available during one heartbeat to generate contraction and relaxation. Area LVP was defined as the integral of systolic-diastolic LVP (contractile and relaxation) during a mean cardiac cycle. AR normalizes the two area indexes under all experimental conditions, i.e., links total available cytosolic [Ca 2ϩ ] for contraction and relaxation in the presence and absence of drugs. The three ratios were used to compare responses among the four drugs, before as well as after reperfusion, irrespective of drug concentration. For example, a doubling of AR would indicate a 50% reduction in the amount of LVP work for a given amount of Ca 2ϩ available.
Protocol. Forty hearts were divided randomly and equally among five groups: no-drug ischemia controls, Bim, BDM, Nif, and Lid groups. Each experiment lasted 210 min (Fig. 1 ). Initial background (before indo 1 loading) measurements were obtained after 30 min of stabilization. On-line recordings were sampled and stored every 1-5 min throughout each experiment. Data shown are limited to four distinct periods: at the end of the washout period (baseline, at 75 min), during drug perfusion before 30 min of ischemia (at 82 min), at 30 min of reperfusion (at 165 min), and during repeat drug perfusion (at 172 min). In this model, LV infarct size is ϳ50% of total ventricular weight after 30 min of ischemia and 60 -120 min of reperfusion (37) (38) (39) . CF was stopped for 30 min to cause global no-flow ischemia. Drugs were perfused at concentrations that submaximally lowered LVP as established from pilot studies. Bim (1 M), BDM (4 mM), Nif (125 nM), or Lid (150 M) was perfused for 2 min, 30 min before ischemia (at 80 min) in each of the drug groups, and again for 2 min at the same concentration beginning after 30 min of reperfusion (at Macintosh from Abacus Concepts; Berkeley, CA) was used to assess within-group differences over time at selected time points: 80 min (baseline) versus the peak response of drugs given before ischemia, 2-min reperfusion (142 min), 30-min reperfusion (170 min), and peak response of drugs given after 30-min reperfusion (Fig. 1) . All ratios were calculated from individual rather than from grouped data. ANOVA was used to assess among-group differences at baseline, at 30-min reperfusion, and at the peak response of drug given before and after ischemia. If F values for the ANOVA were significant, Tukey's multiple-comparison post hoc tests was used to differentiate within-or among-group differences. Differences among means were considered significant when P Ͻ 0.05 (two-tailed). Figure 2 shows representative tracings of simultaneously obtained LVP and myoplasmic [Ca 2ϩ ] (converted from raw Ca 2ϩ transients) before ischemia in the absence and presence of Nif. The indexes of cytosolic [Ca 2ϩ ] and LVP were derived from such traces; Nif reduced both [Ca 2ϩ ] and LVP. Figure 3 , A and B, shows average [Ca 2ϩ ]-LVP loop characteristics and loop area (in parentheses) before 30 min of ischemia and at 30 min of reperfusion in the no-drug control group and in the groups treated with the drugs before ischemia. Before drug treatment and ischemia (Fig. 3A) , there were no differences among the groups in the shape of the loops or the ]-LVP loops (6 -10 cardiac cycles/heart in 8 hearts) during baseline conditions for four negative inotropic drug groups before drug perfusion, and control (no drug), before ischemia. Loop area was acquired by integrating [Ca 2ϩ ]-LVP over 6 -10 beats for 8 hearts/group. Mean loop area (10 3 nM ⅐ mmHg) before and after ischemia for each treatment is shown next to the drug name; there were no differences in loop area. B: averaged [Ca 2ϩ ]-LVP loops at 30 min of reperfusion (no drugs) after hearts were treated with Bim, BDM, Nif, or Lid before ischemia. Loop areas after ischemia were similar in the control and Nif groups, lower and similar in the Lid, Bim, and BDM groups, and not different between the Nif and Lid groups (P Ͻ 0.05). See Table 1 and 5B). Loop area after ischemia was not different from before ischemia for each drug treatment except for Nif, which displayed a larger loop area after ischemia. Note that loop area, per se, furnishes no information on loop orientation, i.e., tall versus broad loops. Table 1 summarizes drug-induced changes in indexes of cytosolic [Ca 2ϩ ] and LVP before and after ischemia. Basal cardiac indexes were similar among all groups before ischemia. Drug treatment before ischemia (drug 1) showed that only Nif reduced systolic, systolic-diastolic, and area [Ca 2ϩ ] compared with basal levels, whereas all drugs decreased systolic, systolic-diastolic, and area LVP. In the no-drug control group at 30 min of reperfusion, systolic, diastolic, systolic-diastolic, and area [Ca 2ϩ ] were significantly higher than their respective baseline values. Systolic, systolic-diastolic, and area LVP decreased and diastolic LVP increased significantly compared with their baselines. Compared with control hearts at 30 min of reperfusion, Nif-treated hearts exhibited the best protection Table 1 Table 1 for significance.
RESULTS
Bim, Nif, and Lid also decreased d [Ca 2ϩ ]/dt max , and BDM had no effect. Postischemic drug treatments, except for Lid, caused a higher d [Ca 2ϩ ]/dt max than the preischemic drug treatments, with or without significant differences in dLVP/dt max between the two treatments. Fig. 6 . Effects of these drugs on the peak negative derivatives (Fig. 7) were qualitatively similar to their effects on the positive derivatives (Fig. 6) Table 1 ) at baseline, during peak responses of drugs given before ischemia, at 30 min of reperfusion, and during peak responses of drugs given after 30 min of reperfusion. These ratios allow for qualitative comparisons of the relative effects of each drug before and after ischemia. Figure 8A shows that BDM, Nif, and Lid, but not Bim, increased VR max before ischemia compared with baseline values. This indicated that BDM, Nif, and Lid decreased contractility more than they reduced peak Ca 2ϩ inflow; Bim did not alter these indexes before ischemia and so preserved the rates of Ca 2ϩ inflow and contraction. VR max at 30 min of reperfusion was much higher than before ischemia in all groups including control except for Nif, which showed no change in VR max . The increase in VR max at 30 min of reperfusion in the other groups indicated a lesser contractile responsiveness to peak Ca 2ϩ , i.e., a higher cytosolic [Ca 2ϩ ] relative to contractility, whereas for the Nif-treated hearts, it indicated improved contractile responsiveness. After ischemia, VR max was increased by BDM and Nif perfusion, whereas Bim and Lid had no effect. Furthermore, postischemic treatment (drug 2) with Bim, Lid, or BDM increased VR max compared with before ischemia (drug 1), but the effect of Nif on VR max after ischemia was not different from preischemia. Figure 8B shows that preischemia drug changes in VR min were similar to preischemia drug changes in VR max . At 30 min of reperfusion, VR min was significantly elevated in all groups except the Nif-pretreated group. Compared with 30 min of reperfusion, Nif and BDM increased VR min , whereas Bim and Lid had no added effect. These results show that Bim and Lid given after reperfusion maintained a slower peak cytosolic Ca 2ϩ outflow during ventricular relaxation. Figure 9 shows that the AR was increased by BDM and Nif before (drug 1) and after ischemia (drug 2) compared with the baseline and 30 min of reperfusion. There was no significant change in AR by Bim or Lid before ischemia or over that caused by ischemia alone. At 30 min of reperfusion, AR was increased significantly above baseline in all groups; only Nif had a lower AR compared with the control group. Postischemia drug (drug 2) treatments showed greater increases in AR for each group compared with the preischemia drug treatment (drug 1).
DISCUSSION
This study shows that, first, reperfusion after 30 min of ischemia in control hearts (no drug) shifts the cytosolic [ ] than LVP after ischemia. Finally, and importantly, each drug, especially Nif, given before ischemia induces a precon- Selection and comparison of negative inotropic drugs. This study follows up our recent work (11) in which we examined the differential alteration of Ca 2ϩ -LVP relationships before and after I/R by four positive inotropic agents. Here, we selected four negative inotropic drugs that either 1) directly block sarcolemmal Ca 2ϩ channels (Nif) or depress myofilament sensitivity (BDM) among other effects; 2) indirectly alter Ca 2ϩ uptake by depressing Na ϩ channel activation to enhance Na ϩ /Ca 2ϩ exchange activity (Lid); or 3) hasten repolarization to reduce transient Ca 2ϩ influx and reduce [Ca 2ϩ ] loading (Bim). As in our recent studies (11, 36) , we used a lower [CaCl 2 ] (1.25 mM) to better distinguish maximal effects on contractility and cytosolic [Ca 2ϩ ] by the positive inotropic agents and selected only one concentration of each drug that provided submaximal depression of LVP. It was not our intent to conduct concentration-response curves to compare the efficacy of these drugs, so we could not directly compare cardiac effects of different drugs. For much of the results (Tables 1 and 2 and Figs. 6 -9), we compared changes in responses only within a drug group.
We chose the isolated heart model to minimize influence of cardiac preload and afterload, blood-borne factors, and autonomic nervous system function. Nif, BDM, and Lid, but not Bim, decreased heart rate by ϳ35%. This indicates that these drugs have direct effects on pacemaker cells and Purkinje fibers possibly via Ca 2ϩ and Na ϩ channels. Lid, for example, may reduce sinoatrial node activity by depressing L-type Ca 2ϩ channels (30) or may depress spontaneous activity of Purkinje fibers by inhibiting the fast Na ϩ channel (1). Three ratios (VR max , VR min , and AR) furnished normalized values for indexes of LVP and Ca 2ϩ and so allowed comparison among drugs. We derived these ratios as they each yield information on the cost of performing work, i.e., the net amount of Ca 2ϩ available to produce a comparable decrease in contractility and relaxation over the cardiac cycle. Therefore, an increase in any ratio meant that contractile responsiveness was decreased, and vice versa. Unlike the other three drugs, Bim perfusion before and after ischemia did not increase VR max , and VR min , and Bim and Lid did not alter AR. These findings indicate that these drugs improved the cost-effective use of available [Ca 2ϩ ] for the contraction and relaxation responses compared with baseline or reperfusion. I/R injury, assessed at 30 min of reperfusion, attenuated this responsiveness as shown by increased VR max and VR min in the control and drug-pretreated groups except for the Nif group, which showed no change in VR max , VR min , and AR.
It should be noted that [Ca 2ϩ ]-LVP loops and the above analyses of various indexes of Ca 2ϩ plotted against LVP do not furnish any temporal information. This, however, can be extracted from our study in which we compared effects of two positive and two negative inotropic drugs on several additional static and dynamic indexes of the [Ca 2ϩ ]-LVP relationship in the absence of ischemia (36) . For those drugs that might reduce heart rate to increase cardiac cycle length, the rates of cytosolic Ca 2ϩ inflow and outflow and the rates of LVP development and relaxation are slowed. The heart rate effect is normalized to some degree by the ratios of an index of Ca 2ϩ to the same index of LVP.
Ischemia-reperfusion and cytosolic [Ca 2ϩ ]-to-LVP relationships. We reported that I/R injury increases cytosolic [Ca 2ϩ ] and decreases contractility in the isolated heart model (3, 11, 56) . We found that [Ca 2ϩ ]-LVP response curves generated by changing extracellular CaCl 2 concentration before and after ischemia showed a reduced maximal contractile response and a rightward shift of the normalized [Ca 2ϩ ]-LVP relationship. This indicated that ischemia causes a reduced maximal activated contractile force and reduced sensitivity to Ca 2ϩ (3, 56) . In this model, I/R injury causes not only cardiac dysfunction but also infarction. In other studies under similar conditions, we found ϳ50 -60% ventricular infarction and ϳ40% recovery of systolic-diastolic LVP after 1-2 h of reperfusion in control hearts (3, 56) . We (11) showed recently that the [Ca 2ϩ ]-LVP loop relationship is altered by ischemia by shifting the loop base upward (increased diastolic LVP) and to the right (increased systolic [Ca 2ϩ ]) on reperfusion. In the present study, we found that I/R injury significantly increased VR max , VR min , and AR. Although the negative inotropic drugs given before ischemia variably preconditioned hearts as evidenced by loop characteristics, we did not observe any difference in contraction (dLVP/dt max ) or relaxation (dLVP/dt min ) effects between control and drug-treated groups at 30 min of reperfusion. However, reperfusion-induced systolic Ca 2ϩ overloading was attenuated in all pretreated hearts after ischemia. These results confirm and extend our previous results that the decrease in myocardial Ca 2ϩ responsiveness and increase in Ca 2ϩ loading can be ameliorated by preconditioning by negative inotropic drugs.
Preconditioning effects of negative inotropic drugs. Ca 2ϩ channel blockers are well known to be cardioprotective. Nif protects when given after I/R injury (12, 25, 34, 35, 41) , but little is known about a possible preconditioning effect before ischemia. Cain et al. (7) conducted in vitro experiments on human atrial trabecular tissue removed from patients receiving Ca 2ϩ channel blockers and found that ischemic preconditioning was prevented; moreover, exogenous CaCl 2 added to the bath elicited preconditioning (8) . We found that Nif reduced both cytosolic [Ca 2ϩ ] and LVP before ischemia and preserved [Ca 2ϩ ]-LVP loop characteristics better than the other drugs that reduced LVP but not systolic [Ca 2ϩ ]. At 30 min of reperfusion, the Nif-treated hearts were more efficient in utilizing Ca 2ϩ (smaller area Ca 2ϩ ) for LVP (area LVP) generation and relaxation (reduced VR max ).
The preconditioning effect of Nif may be indirectly related to its Ca 2ϩ channel-blocking action. For example, adenosine preconditioning may be mediated in part by reduced transsarcolemmal Ca 2ϩ uptake. A 2␣ agonist stimulation of Ca 2ϩ uptake attenuated adenosine preconditioning, and Nif abolished the A 2␣ agonist-induced attenuation of preconditioning (50) . It was suggested that Nif blocked the increase in Ca 2ϩ uptake by A 2␣ agonists as well as their effect to attenuate preconditioning by adenosine. Thus Nif may precondition the heart in part by reducing [Ca 2ϩ ], which then may trigger intracellular events (memory effect) leading to preconditioning.
K ATP channel openers like Bim are well known to elicit preconditioning (9, 13, 20) . BDM given just before the onset of ischemia is cardioprotective (5), possibly by virtue of its effects to inhibit actinomyosin ATPase and reduce ATP consumption (45) or to decrease myofilament Ca 2ϩ sensitivity (17, 21, 22) . Overall, Bim, like Nif, may be effective therapeutically in the postischemic heart as K ATP channel-induced preconditioning is a potential design for clinical trials, especially ]/dtmax)/(dLVP/dtmax), VRmax, at baseline, during peak response of drugs before ischemia (drug 1), at 30 min of reperfusion, and during the peak response of drugs after ischemia (drug 2). Reperfusion at 30 min increased VRmax in all groups except Nif. Before ischemia (drug 1) all drugs except BIM increased VRmax; after ischemia (drug 2), Nif and BDM, but not Bim or Lid, increased VRmax. B: ratio of (d [Ca 2ϩ ]/dtmin)/(dLVP/dtmin), VRmin, at baseline, during peak response of drugs before ischemia, at 30 min of reperfusion, and during the peak response of drugs after ischemia. The effect of the drugs before (drug 1) and after (drug 2) ischemia were qualitatively similar to Fig. 6A. in patients subjected to short periods of ischemia, e.g., in angioplasty.
Lid given before or early during ischemia protects against I/R injury (16, 32, 52, 54, 55) , but it appears not to be protective when given after ischemia (16) . Possible mechanisms for Lid preconditioning are its effects on blocking Na ϩ channels, its antioxidant activity (14), its energy-sparing effect due to reduced Na,K-ATPase activity, and its indirect effect to reduce Ca 2ϩ loading secondary to reduced Na ϩ /Ca 2ϩ exchange. Any of these potential effects of negative inotropic drugs must only initiate, but not mediate, the process of preconditioning because the drug is washed out before ischemia.
Effects of negative inotropic drugs on [Ca 2ϩ ]-LVP relationships. Cardiac K ATP channels are believed to play a role in modulating cardiac function, particularly under conditions of metabolic stress, as in I/R injury (9) . K ATP channel opening shortens the AP by enhancing phase 3 repolarization; this inhibits the L-type Ca 2ϩ channel and slows reverse-mode Na ϩ /Ca 2ϩ exchanger. These actions may lead to a decrease in cytosolic [Ca 2ϩ ] and a subsequent reduction in contractility (40) . Bim had a small negative inotropic and vasodilatory effects when given before ischemia, as shown previously (42) . In our study, Bim reduced cytosolic Ca 2ϩ loading on reperfusion compared with the control group and depressed both LVP and [Ca 2ϩ ] compared with 30 min of reperfusion; this suggests that after ischemia the myocardium may become sensitized to the K ATP channel agonist, perhaps as a result of altered ATP level in the vicinity of K ATP channels (42) . This notion is supported by findings that the stunned myocardium may have a reduced amount of ATP for an extended period on reperfusion (58) . Postischemia Bim also improved contractile responsiveness, VR max and AR, for the [Ca 2ϩ ] available. This may be due in part to an increase in CF after ischemia (Table 2) .
BDM exerts its negative inotropic actions by reducing the Ca 2ϩ current to shorten the AP, by inhibiting cross-bridge function (45), and by decreasing myofilament sensitivity to Ca 2ϩ (21, 22 (Figs. 4 and 5) , by the smaller AR after reperfusion, and by the increased VR max and VR min compared with Bim. In our recent study (36) , we showed that Nif exhibited less loop hysteresis compared with Lid; this suggested a more efficient linkage of [Ca 2ϩ ] to elicit contraction with Lid than with Nif. Lid exerts its negative inotropic action primarily by suppressing the fast Na ϩ channel (32, (52) (53) (54) 57) and possibly also by disrupting active Ca 2ϩ transport by the SR (57). In our study, hearts briefly exposed to Lid and washed out before ischemia were protected against Ca 2ϩ overload (Table 1) . Lid depressed CF and MV O 2 in the preischemic heart but not in the postischemic heart, which suggests that depression of LVP before ischemia could be due in part to decreased metabolic Fig. 9 . Ratio of area Ca 2ϩ to area LVP, AR, at baseline, during the peak response of drugs before ischemia (drug 1), at 30 min of reperfusion, and during the peak response of drugs after ischemia (drug 2). Reperfusion at 30 min increased AR in all groups.
function. Lid affinity for the Na ϩ channel increases during I/R injury due to reduced intracellular pH and inactivation of the channel (53 ]-LVP loop characteristics. Summary and conclusions. This study first provides a better understanding of the mechanisms and differences among negative inotropic drugs on several [Ca 2ϩ ]-LVP indexes during the cardiac cycle. We showed that differently acting negative inotropic agents given before and after ischemia modulate [Ca 2ϩ ]-LVP relationships differently both within and across treatment comparisons. Second, using these same indexes, we showed that these drugs differently precondition hearts. In in vivo blood-perfused and innervated hearts, the effects of these drugs given over a period of time would likely be different from our observations, but the overall effect of cytosolic [Ca 2ϩ ] on beat-to-beat contractility and relaxation is probably similar. Thus, if these isolated heart results were to be applied to the clinical setting, they would suggest that diverse classes of drugs like Na ϩ and Ca 2ϩ channel blockers, K ATP channel openers, and actinomyosin ATPase inhibitors remain effective in reducing contractility after ischemia, albeit at higher levels of cytosolic [Ca 2ϩ ]. Moreover, in a clinical setting, these drugs may elicit cardiac preconditioning as a defense against I/R injury.
